Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8440905 | European Journal of Cancer | 2016 | 9 Pages |
Abstract
Binimetinib induces a specific retinopathy with daily fluctuations depending on the time interval after medication. The retinopathy partially recovers, but can still be detected many months later. Retinal thinning, possible first signs of retinal atrophy have been observed after long-term treatment, but, so far, without functional relevance.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
U. Urner-Bloch, M. Urner, N. Jaberg-Bentele, A.L. Frauchiger, R. Dummer, S.M. Goldinger,